Balance Wealth
ALAB icon

Balance Wealth’s Astera Labs ALAB Stock Holding History

Balance Wealth’s Portfolio ALAB Stock Details ALAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$641 Buy
+2
New +$643 ﹤0.01% 873

Other funds holding ALAB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $165B AUM 72.14% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return

Balance Wealth's ALAB Position: Q3 2026 in Review

Balance Wealth opened a new position in Astera Labs (ALAB) in Q3 2026: 2 shares worth $641. The stake represents ﹤0.01% of the portfolio and ranks #873 among its holdings.

800 funds tracked by Wall St. Rank hold ALAB as of Q3 2026.

  • Balance Wealth held 2 shares of Astera Labs worth $641 as of Q3 2026.
  • Astera Labs was a new Balance Wealth position in Q3 2026.
  • Astera Labs made up ﹤0.01% of Balance Wealth's portfolio in Q3 2026, its #873 holding.
  • 800 funds tracked by Wall St. Rank held Astera Labs as of Q3 2026.

Based on Balance Wealth's 13F filing for Q3 2026, filed 27 Oct 2026.